USP21 negatively regulates antiviral response by acting as a RIG-I deubiquitinase

Journal of Experimental Medicine

Volumn 211, Issue 2, 2014, Pages 313-328

  Fan, Yihui ^a,b   Mao, Renfang ^a   Yu, Yang ^a   Liu, Shangfeng ^b   Shi, Zhongcheng ^d   Cheng, Jin ^a   Zhang, Huiyuan ^e   An, Lei ^e   Zhao, Yanling ^a   Xu, Xin ^a   Chen, Zhenghu ^b   Kogiso, Mari ^a   Zhang, Dekai ^d   Zhang, Hong ^a,e   Zhang, Pumin ^a   Jung, Jae U ^f   Li, Xiaonan ^a   Xu, Guotong ^b,c   Yang, Jianhua ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TONGJI HOSPITAL OF TONGJI UNIVERSITY   (China)

^c TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^d TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; CARD SIGNALING ADAPTOR PROTEINS; DEAD-BOX RNA HELICASES; DNA-BINDING PROTEINS; FEMALE; IMMUNITY, INNATE; INTERFERON REGULATORY FACTOR-3; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, SCID; RHABDOVIRIDAE INFECTIONS; TRANSCRIPTION FACTORS; UBIQUITIN THIOLESTERASE; UBIQUITIN-SPECIFIC PROTEASES; VESICULOVIRUS;

EID: 84893721948     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20122844     Document Type: Article

References (50)

1. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell. 124:783-801. http://dx.doi.org/10.1016/j.cell.2006 .02.015
2. Bhoj, V.G., and Z.J. Chen. 2009. Ubiquitylation in innate and adaptive immunity. Nature. 458:430-437. http://dx.doi.org/10.1038/nature07959
3. Fan, Y.H., Y. Yu, Y. Shi, W.J. Sun, M. Xie, N. Ge, R.F. Mao, A. Chang, G. Xu, M.D. Schneider, et al. 2010. Lysine 63-linked polyubiquitination of TAK1 at lysine 158 is required for tumor necrosis factor alpha-and interleukin-1 beta-induced IKK/NF-kappaB and JNK/AP-1 activation. J. Biol. Chem. 285:5347-5360. http://dx.doi.org/10.1074/jbc.M109.076976
4. Fan, Y.H., Y. Yu, R.F. Mao, X.J. Tan, G.F. Xu, H. Zhang, X.B. Lu, S.B. Fu, and J. Yang. 2011. USP4 targets TAK1 to downregulate TNF?-induced NF-?B activation. Cell Death Differ. 18:1547-1560. http://dx.doi.org/10.1038/cdd.2011.11
5. Friedman, C.S., M.A. O'Donnell, D. Legarda-Addison, A. Ng, W.B. Cárdenas, J.S. Yount, T.M. Moran, C.F. Basler, A. Komuro, C.M. Horvath, et al. 2008. The tumour suppressor CYLD is a negative regulator of RIG-Imediated antiviral response. EMBO Rep. 9:930-936. http://dx.doi .org/10.1038/embor.2008.136
6. Fujita, T. 2009. A nonself RNA pattern: tri-p to panhandle. Immunity. 31:4-5. http://dx.doi.org/10.1016/j.immuni.2009.06.014
7. Gack, M.U., Y.C. Shin, C.H. Joo, T. Urano, C. Liang, L. Sun, O. Takeuchi, S. Akira, Z. Chen, S. Inoue, and J.U. Jung. 2007. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature. 446:916-920. http://dx.doi.org/10.1038/nature05732
8. Gack, M.U., A. Kirchhofer, Y.C. Shin, K.S. Inn, C. Liang, S. Cui, S. Myong, T. Ha, K.P. Hopfner, and J.U. Jung. 2008. Roles of RIG-I N-terminal tandem CARD and splice variant in TRIM25-mediated antiviral signal transduction. Proc. Natl. Acad. Sci. USA. 105:16743-16748. http://dx.doi .org/10.1073/pnas.0804947105
9. Gao, D., Y.K. Yang, R.P. Wang, X. Zhou, F.C. Diao, M.D. Li, Z.H. Zhai, Z.F. Jiang, and D.Y. Chen. 2009. REUL is a novel E3 ubiquitin ligase and stimulator of retinoic-acid-inducible gene-I. PLoS ONE. 4:e5760. http://dx .doi.org/10.1371/journal.pone.0005760
10. García-Santisteban, I., S. Bañuelos, and J.A. Rodríguez. 2012. A global survey of CRM1-dependent nuclear export sequences in the human deubiquitinase family. Biochem. J. 441:209-217. http://dx.doi.org/10.1042/ BJ20111300
11. Honda, K., A. Takaoka, and T. Taniguchi. 2006. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity. 25:349-360. http://dx.doi.org/10.1016/j.immuni .2006.08.009
12. Kato, H., S. Sato, M. Yoneyama, M. Yamamoto, S. Uematsu, K. Matsui, T. Tsujimura, K. Takeda, T. Fujita, O. Takeuchi, and S. Akira. 2005. Cell typespecific involvement of RIG-I in antiviral response. Immunity. 23:19-28. http://dx.doi.org/10.1016/j.immuni.2005.04.010
13. Kato, H., O. Takeuchi, S. Sato, M. Yoneyama, M. Yamamoto, K. Matsui, S. Uematsu, A. Jung, T. Kawai, K.J. Ishii, et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 441:101-105. http://dx.doi.org/10.1038/nature04734
14. Kawai, T., K. Takahashi, S. Sato, C. Coban, H. Kumar, H. Kato, K.J. Ishii, O. Takeuchi, and S. Akira. 2005. IPS-1, an adaptor triggering RIG-I-and Mda5-mediated type I interferon induction. Nat. Immunol. 6:981-988. http://dx.doi.org/10.1038/ni1243
15. Kayagaki, N., Q. Phung, S. Chan, R. Chaudhari, C. Quan, K.M. O'Rourke, M. Eby, E. Pietras, G. Cheng, J.F. Bazan, et al. 2007. DUBA: a deubiquitinase that regulates type I interferon production. Science. 318:1628-1632. http://dx.doi.org/10.1126/science.1145918
16. Komander, D., M.J. Clague, and S. Urbé. 2009. Breaking the chains: structure and function of the deubiquitinases. Nat. Rev. Mol. Cell Biol. 10:550-563. http://dx.doi.org/10.1038/nrm2731
17. Lin, R., L. Yang, P. Nakhaei, Q. Sun, E. Sharif-Askari, I. Julkunen, and J. Hiscott. 2006. Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20. J. Biol. Chem. 281:2095-2103. http://dx.doi.org/10.1074/jbc.M510326200
18. Malakhova, O.A., K.I. Kim, J.K. Luo, W. Zou, K.G. Kumar, S.Y. Fuchs, K. Shuai, and D.E. Zhang. 2006. UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity. EMBO J. 25:2358-2367. http://dx.doi.org/10.1038/sj.emboj.7601149
19. Meylan, E., J. Curran, K. Hofmann, D. Moradpour, M. Binder, R. Bartenschlager, and J. Tschopp. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature. 437:1167-1172. http://dx.doi.org/10.1038/nature04193
20. Moser, K.L., J.A. Kelly, C.J. Lessard, and J.B. Harley. 2009. Recent insights into the genetic basis of systemic lupus erythematosus. Genes Immun. 10:373-379. http://dx.doi.org/10.1038/gene.2009.39
21. Nakagawa, T., T. Kajitani, S. Togo, N. Masuko, H. Ohdan, Y. Hishikawa, T. Koji, T. Matsuyama, T. Ikura, M. Muramatsu, and T. Ito. 2008. Deubiquitylation of histone H2A activates transcriptional initiation via trans-histone crosstalk with H3K4 di-and trimethylation. Genes Dev. 22:37-49. http://dx .doi.org/10.1101/gad.1609708
22. Nijman, S.M., M.P. Luna-Vargas, A. Velds, T.R. Brummelkamp, A.M. Dirac, T.K. Sixma, and R. Bernards. 2005. A genomic and functional inventory of deubiquitinating enzymes. Cell. 123:773-786. http://dx.doi .org/10.1016/j.cell.2005.11.007
23. Oshiumi, H., M. Matsumoto, S. Hatakeyama, and T. Seya. 2009. Riplet/ RNF135, a RING finger protein, ubiquitinates RIG-I to promote interferon-beta induction during the early phase of viral infection. J. Biol. Chem. 284:807-817. http://dx.doi.org/10.1074/jbc.M804259200
24. Oshiumi, H., M. Miyashita, N. Inoue, M. Okabe, M. Matsumoto, and T. Seya. 2010. The ubiquitin ligase Riplet is essential for RIG-I-dependent innate immune responses to RNA virus infection. Cell Host Microbe. 8:496-509. http://dx.doi.org/10.1016/j.chom.2010.11.008
25. Parvatiyar, K., G.N. Barber, and E.W. Harhaj. 2010. TAX1BP1 and A20 inhibit antiviral signaling by targeting TBK1-IKKi kinases. J. Biol. Chem. 285:14999-15009. http://dx.doi.org/10.1074/jbc.M110.109819
26. Ramos, P.S., A.H. Williams, J.T. Ziegler, M.E. Comeau, R.T. Guy, C.J. Lessard, H. Li, J.C. Edberg, R. Zidovetzki, L.A. Criswell, et al. 2011. Genetic analyses of interferon pathway-related genes reveal multiple new loci associated with systemic lupus erythematosus. Arthritis Rheum. 63:2049-2057. http://dx.doi.org/10.1002/art.30356
27. Ritchie, K.J., C.S. Hahn, K.I. Kim, M. Yan, D. Rosario, L. Li, J.C. de la Torre, and D.E. Zhang. 2004. Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection. Nat. Med. 10:1374-1378. http:// dx.doi.org/10.1038/nm1133
28. Saitoh, T., M. Yamamoto, M. Miyagishi, K. Taira, M. Nakanishi, T. Fujita, S. Akira, N. Yamamoto, and S. Yamaoka. 2005. A20 is a negative regulator of IFN regulatory factor 3 signaling. J. Immunol. 174:1507-1512.
29. Satoh, T., H. Kato, Y. Kumagai, M. Yoneyama, S. Sato, K. Matsushita, T. Tsujimura, T. Fujita, S. Akira, and O. Takeuchi. 2010. LGP2 is a positive regulator of RIG-I-and MDA5-mediated antiviral responses. Proc. Natl. Acad. Sci. USA. 107:1512-1517. http://dx.doi.org/10.1073/pnas.0912986107
30. Seth, R.B., L. Sun, C.K. Ea, and Z.J. Chen. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell. 122:669-682. http://dx.doi .org/10.1016/j.cell.2005.08.012
31. Shembade, N., N.S. Harhaj, D.J. Liebl, and E.W. Harhaj. 2007. Essential role for TAX1BP1 in the termination of TNF-alpha-, IL-1-and LPSmediated NF-kappaB and JNK signaling. EMBO J. 26:3910-3922. http://dx.doi.org/10.1038/sj.emboj.7601823
32. Shembade, N., N.S. Harhaj, K. Parvatiyar, N.G. Copeland, N.A. Jenkins, L.E. Matesic, and E.W. Harhaj. 2008. The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20. Nat. Immunol. 9:254-262. http:// dx.doi.org/10.1038/ni1563
33. Shembade, N., K. Parvatiyar, N.S. Harhaj, and E.W. Harhaj. 2009. The ubiquitin-editing enzyme A20 requires RNF11 to downregulate NFkappaB signalling. EMBO J. 28:513-522. http://dx.doi.org/10.1038/ emboj.2008.285
34. Shembade, N., A. Ma, and E.W. Harhaj. 2010. Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes. Science. 327:1135-1139. http://dx.doi.org/10.1126/science.1182364
35. Takeuchi, O., and S. Akira. 2010. Pattern recognition receptors and inflammation. Cell. 140:805-820. http://dx.doi.org/10.1016/j.cell.2010.01.022
36. Urbé, S., H. Liu, S.D. Hayes, C. Heride, D.J. Rigden, and M.J. Clague. 2012. Systematic survey of deubiquitinase localization identifies USP21 as a regulator of centrosome-and microtubule-associated functions. Mol. Biol. Cell. 23:1095-1103. http://dx.doi.org/10.1091/mbc.E11-08-0668
37. Wang, Y.Y., L. Li, K.J. Han, Z. Zhai, and H.B. Shu. 2004. A20 is a potent inhibitor of TLR3-and Sendai virus-induced activation of NF-kappaB and ISRE and IFN-beta promoter. FEBS Lett. 576:86-90. http://dx .doi.org/10.1016/j.febslet.2004.08.071
38. Wertz, I.E., and V.M. Dixit. 2010. Signaling to NF-kappaB: regulation by ubiquitination. Cold Spring Harb. Perspect. Biol. 2:a003350. http://dx.doi .org/10.1101/cshperspect.a003350
39. Wertz, I.E., K.M. O'Rourke, H. Zhou, M. Eby, L. Aravind, S. Seshagiri, P. Wu, C. Wiesmann, R. Baker, D.L. Boone, et al. 2004. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature. 430:694-699. http://dx.doi.org/10.1038/nature02794
40. Xia, Z.P., L. Sun, X. Chen, G. Pineda, X. Jiang, A. Adhikari, W. Zeng, and Z.J. Chen. 2009. Direct activation of protein kinases by unanchored polyubiquitin chains. Nature. 461:114-119. http://dx.doi.org/10.1038/ nature08247
41. Xu, L.G., Y.Y. Wang, K.J. Han, L.Y. Li, Z. Zhai, and H.B. Shu. 2005. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell. 19:727-740. http://dx.doi.org/10.1016/j.molcel.2005.08.014
42. Xu, G., X. Tan, H. Wang, W. Sun, Y. Shi, S. Burlingame, X. Gu, G. Cao, T. Zhang, J. Qin, and J. Yang. 2010. Ubiquitin-specific peptidase 21 inhibits tumor necrosis factor alpha-induced nuclear factor kappaB activation via binding to and deubiquitinating receptor-interacting protein 1. J. Biol. Chem. 285:969-978. http://dx.doi.org/10.1074/jbc.M109.042689
43. Yamazaki, K., J. Gohda, A. Kanayama, Y. Miyamoto, H. Sakurai, M. Yamamoto, S. Akira, H. Hayashi, B. Su, and J. Inoue. 2009. Two mechanistically and temporally distinct NF-kappaB activation pathways in IL-1 signaling. Sci. Signal. 2:ra66. http://dx.doi.org/10.1126/scisignal.2000387
44. Ye, Y., M. Akutsu, F. Reyes-Turcu, R.I. Enchev, K.D. Wilkinson, and D. Komander. 2011. Polyubiquitin binding and cross-reactivity in the USP domain deubiquitinase USP21. EMBO Rep. 12:350-357. http:// dx.doi.org/10.1038/embor.2011.17
45. Yoneyama, M., and T. Fujita. 2009. RNA recognition and signal transduction by RIG-I-like receptors. Immunol. Rev. 227:54-65. http://dx.doi .org/10.1111/j.1600-065X.2008.00727.x
46. Yoneyama, M., M. Kikuchi, T. Natsukawa, N. Shinobu, T. Imaizumi, M. Miyagishi, K. Taira, S. Akira, and T. Fujita. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5:730-737. http://dx.doi.org/10 .1038/ni1087
47. Zeng, W., M. Xu, S. Liu, L. Sun, and Z.J. Chen. 2009. Key role of Ubc5 and lysine-63 polyubiquitination in viral activation of IRF3. Mol. Cell. 36:315-325. http://dx.doi.org/10.1016/j.molcel.2009.09.037
48. Zeng, W., L. Sun, X. Jiang, X. Chen, F. Hou, A. Adhikari, M. Xu, and Z.J. Chen. 2010. Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell. 141:315-330. http://dx.doi.org/10.1016/j.cell.2010.03.029
49. Zhang, M., X. Wu, A.J. Lee, W. Jin, M. Chang, A. Wright, T. Imaizumi, and S.C. Sun. 2008. Regulation of IkappaB kinase-related kinases and antiviral responses by tumor suppressor CYLD. J. Biol. Chem. 283:18621-18626. http://dx.doi.org/10.1074/jbc.M801451200
50. Zhang, M., A.J. Lee, X. Wu, and S.C. Sun. 2011. Regulation of antiviral innate immunity by deubiquitinase CYLD. Cell. Mol. Immunol. 8:502-504. http://dx.doi.org/10.1038/cmi.2011.42